Telmisartan & Benidipine Hydrochloride Tablets – To Control for Vascular Hypertension.
ZENIDIP Tablets: The Dual composition of Temisartan 40 mg + Benidipine Hydrochloride 4mg, well-established antihypertensives—Telmisartan, an ARB with metabolic neutrality, and Benidipine, a unique dihydropyridine CCB with triple channel blockade (Ca²⁺, Na⁺, K⁺). The combination targets both vascular resistance and fluid volume, making it ideal for patients with suboptimal control on monotherapy.
Recommended By Specialists:
✅General Physicians: IT is preferred to treat the disease associated with routine diagnosis and long-term management of hypertension
✅Cardiologists: It is preferred to treat the disease associated with patients with hypertension, heart disease, or high cardiovascular risk
✅Nephrologists: It is preferred to treat the disease associated with patients with hypertension related to kidney disorders or chronic kidney disease (CKD)
Key benefits of Telmisartan & Benidipine Hydrochloride Tablets – ZENIDIP Tablets:
✅Complementary Mechanism of Action – Telmisartan blocks angiotensin-II, while Benidipine acts as a long-acting calcium channel blocker for synergistic BP lowering.
✅Vascular Selectivity & Renal Safety—Benidipine improves endothelial function with minimal reflex tachycardia, while telmisartan offers cardio-renal protection.
✅Once-Daily Stable BP Control— The long duration of action of both agents ensures 24-hour efficacy with good patient compliance.
INDICATIONS:
✅Mild to Moderate Hypertension
✅High BP with Metabolic Syndrome
✅Patients Needing Dual Therapy
✅Renal & Cardiac Risk Management
✅Inadequate BP Control on ARB Alone










